Richard Bungay

Director/Board Member at CAMBRIDGE COGNITION HOLDINGS PLC

Net worth: 4 987 $ as of 31/05/2026

57 year

50 connections

Health Technology

Technology Services

Consumer Services

Profile

Richard Edward Bungay is currently Director at Chroma Therapeutics Ltd. since 2004, Secretary & Director at Macrotarg Ltd. since 2011, Non-Executive Director at Nasdaq Corporate Solutions International Ltd., Non-Executive Director at Cambridge Cognition Holdings Plc since 2020, Secretary & Director at Diurnal Ltd., Director at Monument Therapeutics Ltd., and Chief Operating Officer at Sitala Bio Ltd. Former roles include Chief Executive Officer at Imophoron Ltd. from 2022 to 2024, Chief Financial Officer & Executive Director at Immedica Group Ltd. from 2017 to 2023, Finance Director-Respiratory & Inflammation Area at AstraZeneca PLC from 1998 to 2000, Director-Corporate Communications at Celltech Group Plc, Chief Financial Officer & Non-Executive Director at Glide Pharmaceutical Technologies Ltd., Chief Financial Officer at Verona Pharma Plc from 2013 to 2014, and Chief Operating & Financial Officer at Mereo BioPharma Group Plc.
Education includes an undergraduate degree from The University of Nottingham.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CAMBRIDGE COGNITION HOLDINGS PLC 0.02%	31/12/2024	10,000 ( 0.02% )	4 987 $	31/05/2026

Richard Bungay active positions

Companies	Position	Start
CAMBRIDGE COGNITION HOLDINGS PLC	Director/Board Member	14/09/2020
Chroma Therapeutics Ltd. Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation	Director/Board Member	01/10/2004
Nasdaq Corporate Solutions International Ltd. Nasdaq Corporate Solutions International Ltd. Packaged SoftwareTechnology Services Develops and manages software for corporate communications and reputation management solutions	Director/Board Member	-
Diurnal Ltd. Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Develops hormone therapeutics	Director/Board Member	18/01/2017
Macrotarg Ltd. Macrotarg Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Director/Board Member	04/05/2011
Monument Therapeutics Ltd. Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system	Director/Board Member	-
Sitala Bio Ltd. Sitala Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for neurodegenerative and inflammatory diseases	Chief Operating Officer	-

All active positions of Richard Bungay

Former positions of Richard Bungay

Companies	Position	End
Imophoron Ltd. Imophoron Ltd. BiotechnologyHealth Technology Develops a novel vaccine platform for use on emerging infectious diseases	Chief Executive Officer	01/12/2024
DIUL GROUP	Chief Executive Officer	01/02/2023
░░░░░ ░░░░░░░░░ ░░░░░ ░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Richard Bungay's experience

Training of Richard Bungay

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Bungay's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Celltech Group Plc Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals	Health Technology
Chroma Therapeutics Ltd. Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation	Health Technology
The University of Nottingham The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Verona Pharma Plc Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases	Health Technology
Glide Pharmaceutical Technologies Ltd. Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Diurnal Group Ltd. Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes therapeutics for neuropsychiatric, neurological & neuroendocrine disorders	Health Technology
Macrotarg Ltd. Macrotarg Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Health Technology
Nasdaq Corporate Solutions International Ltd. Nasdaq Corporate Solutions International Ltd. Packaged SoftwareTechnology Services Develops and manages software for corporate communications and reputation management solutions	Technology Services
Cambridge Cognition Holdings Plc Cambridge Cognition Holdings Plc Packaged SoftwareTechnology Services Provides cognitive assessment software for clinical trials, academic research and healthcare provision	Technology Services
Mereo BioPharma Group Plc Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Diurnal Ltd. Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Develops hormone therapeutics	Health Technology
Monument Therapeutics Ltd. Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system	Health Technology
Imophoron Ltd. Imophoron Ltd. BiotechnologyHealth Technology Develops a novel vaccine platform for use on emerging infectious diseases	Health Technology
Sitala Bio Ltd. Sitala Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for neurodegenerative and inflammatory diseases	Health Technology